Cargando…
Bilateral adrenocortical carcinoma in a patient with multiple endocrine neoplasia type 1 (MEN1) and a novel mutation in the MEN1 gene
The incidence of adrenal involvement in MEN1 syndrome has been reported between 9 and 45%, while the incidence of adrenocortical carcinoma (ACC) in MEN1 patients has been reported between 2.6 and 6%. In the literature data only unilateral development of ACCs in MEN1 patients has been reported. We re...
Autores principales: | Griniatsos, John E, Dimitriou, Nikoletta, Zilos, Athanassios, Sakellariou, Stratigoula, Evangelou, Konstantinos, Kamakari, Smaragda, Korkolopoulou, Penelope, Kaltsas, Gregory |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039620/ https://www.ncbi.nlm.nih.gov/pubmed/21266030 http://dx.doi.org/10.1186/1477-7819-9-6 |
Ejemplares similares
-
Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)
por: Thakker, Rajesh V.
Publicado: (2014) -
Diagnosis and Management of Multiple Endocrine Neoplasia Type 1 (MEN1)
por: Dreijerink, Koen MA, et al.
Publicado: (2005) -
The role of nuclear imaging in multiple endocrine neoplasia 1 (MEN 1)
por: Wosnitzer, Brian, et al.
Publicado: (2015) -
Breast cancer in multiple endocrine neoplasia type 1 (MEN1)
por: Cheah, Seong Keat, et al.
Publicado: (2021) -
Diagnosis and Treatment of Gastrinomas in Multiple Endocrine Neoplasia Type 1 (MEN-1)
por: Plöckinger, Ursula
Publicado: (2012)